Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$517K Sell
1,429
-84
-6% -$28.8K 0.05% 310
2026
Q1
$532K Sell
1,513
-19
-1% -$6.77K 0.07% 271
2025
Q4
$501K Sell
1,532
-56
-4% -$17.8K 0.06% 280
2025
Q3
$448K Buy
1,588
+578
+57% +$168K 0.06% 280
2025
Q2
$282K Buy
1,010
+89
+10% +$25.2K 0.05% 324
2025
Q1
$287K Sell
921
-261
-22% -$77.1K 0.06% 280
2024
Q4
$308K Buy
+1,182
New +$351K 0.06% 293

Other funds holding AMGN

United Advisor Group's AMGN Position: Q2 2026 in Review

United Advisor Group reduced its Amgen (AMGN) stake by 5.6% in Q2 2026, selling an estimated $28.8K and leaving 1,429 shares worth $517K. The position accounts for 0.05% of the portfolio, ranked #310.

United Advisor Group first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $532K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • United Advisor Group held 1,429 shares of Amgen worth $517K as of Q2 2026.
  • United Advisor Group sold 84 Amgen shares in Q2 2026, an estimated $28.8K.
  • Amgen made up 0.05% of United Advisor Group's portfolio in Q2 2026, its #310 holding.
  • United Advisor Group first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • United Advisor Group's Amgen position peaked at $532K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on United Advisor Group's 13F filing for Q2 2026, filed 29 Jul 2026.